Technology | August 29, 2006

Added Security for Difficult-to-Defibrillate Hearts Available


The Atlas II ICD (implantable cardioverter defibrillator) and Atlas II HF CRT-D (cardiac resynchronization therapy defibrillator) devices are capable of delivering unsurpassed energy, giving added security to patients whose hearts are especially difficult to defibrillate. The devices also feature enhanced telemetry speed for faster communications — up to five times faster than predecessor devices — which results in quicker, more convenient follow-up visits for patients and physicians. The devices include a "patient notifier" that vibrates to alert patients, including those who have difficulty hearing, of critical changes in device function so they know to contact their physicians. In addition to patient notification, speed and energy (42 joules of stored and 36 joules of delivered energy), the Atlas II also features proprietary St. Jude Medical technology designed to help devices meet the needs of patients who require high levels of defibrillation therapy and allow optimizing of sensing parameters that may protect against inappropriate ICD shocks.


Related Content

News | Implantable Cardioverter Defibrillator (ICD)

Sept. 2, 2024 – Medtronic recently shared long-term results from the global Extravascular Implantable Cardioverter ...

Home September 05, 2024
Home
News | Implantable Cardioverter Defibrillator (ICD)

February 12, 2024 — BIOTRONIK, a leader in implantable medical device technology, announced today they will solely ...

Home February 12, 2024
Home
News | Implantable Cardioverter Defibrillator (ICD)

October 23, 2023 — Medtronic plc, a global leader in healthcare technology, has received U.S. Food and Drug ...

Home October 23, 2023
Home
News | Implantable Cardioverter Defibrillator (ICD)

August 28, 2023 — Is the routine implantation of an implantable cardioverter defibrillator (ICD) in myocardial ...

Home August 28, 2023
Home
News | Implantable Cardioverter Defibrillator (ICD)

August 28, 2023 — Upgrade to cardiac resynchronization therapy with a defibrillator (CRT-D) reduces morbidity and ...

Home August 28, 2023
Home
News | Implantable Cardioverter Defibrillator (ICD)

July 18, 2023 — The U.S. Food and Drug Administration (FDA) has issued a Class I recall on the Medtronic ICDs and CRT-Ds ...

Home July 18, 2023
Home
News | Implantable Cardioverter Defibrillator (ICD)

March 7, 2023 — Ninety-five percent of athletes with a diagnosed and treated genetic heart disease experienced no ...

Home March 07, 2023
Home
News | Implantable Cardioverter Defibrillator (ICD)

February 17, 2023 — Medtronic plc has received CE (Conformité Européenne) Mark for the Aurora EV-ICD MRI SureScan ...

Home February 17, 2023
Home
News | Implantable Cardioverter Defibrillator (ICD)

August 29, 2022 — Medtronic plc announced that its investigational EV ICD System – a first-of-its-kind defibrillator ...

Home August 29, 2022
Home
Subscribe Now